Schulman, 1967 - Google Patents
The fractionation of rabbit reticulocytes in dextran density gradientsSchulman, 1967
- Document ID
- 12301457687482019789
- Author
- Schulman H
- Publication year
- Publication venue
- Biochimica et Biophysica Acta (BBA)-General Subjects
External Links
Snippet
251 BBA 25829 THE FRACTIONATION OF RABBIT RETICULOCYTES IN DEXTRAN DENSITY
GRADIENTS A method is described for the preparation o Page 1 BIOCHIMiCA ET BIOPHYSICA
ACTA 251 BBA 25829 THE FRACTIONATION OF RABBIT RETICULOCYTES IN DEXTRAN …
- 229920002307 Dextran 0 title abstract description 23
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pertoft et al. | Separation of various blood cells in colloidal silica-polyvinylpyrrolidone gradients | |
Ferrante et al. | A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique | |
Rothschild | The isolation of microsomal membranes | |
Schmidt et al. | Preparation of Platelet Suspensions from Whole Blood in Buffer: Description of a Method Which Gives a Large Platelet Yield | |
Ehrenfeld et al. | Soluble RNA polymerase complex from poliovirus-infected HeLa cells | |
Schulman | The fractionation of rabbit reticulocytes in dextran density gradients | |
Rowley et al. | Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system | |
Carter et al. | Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations | |
Minor et al. | A method for separating and concentrating platelets from normal human blood | |
JP3416779B2 (en) | Method and apparatus for testing blood units for viral contamination | |
Day | Basophil leucocyte separation from human peripheral blood: a technique for their isolation in high purity and high yield | |
Miura et al. | Efficacy of several plasma components in a young boy with chronic thrombocytopenia and hemolytic anemia who responds repeatedly to normal plasma infusions | |
CA1063019A (en) | Extracts of the haemopoietic system | |
Harker et al. | Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor | |
JP2002204700A (en) | Method for validating virus deactivating process | |
Bashir et al. | Neutrophil function is preserved in a pooled granulocyte component prepared from whole blood donations | |
JP3393646B2 (en) | Preserved non-infectious control cells used to confirm disease by blood test | |
Bauer | Electrophoretic separation of cells | |
Branch et al. | Erythrocyte Age-fractionation Using a Percollκ-Renografin® Density Gradient: Application to Autologous Red Cell Antigen Determinations in Recently Transfused Patients | |
CN113980814B (en) | Composition for rapidly lysing peripheral red blood cells and application thereof | |
Sorette et al. | Improved isolation of normal human reticulocytes via exploitation of chloride-dependent potassium transport | |
Abrahamsen et al. | Stimulatory effect of counterflow centrifugal elutriation in large‐scale separation of peripheral blood monocytes can be reversed by storing the cells at 37° c | |
US5763204A (en) | Preparation of preserved, non-infectious control cell for use in the identification of a disease through blood testing | |
McClelland et al. | The total N-acetyl neuraminic acid content of human normal and lymphatic leukaemic lymphocytes | |
Hill et al. | Use of arabinogalactan to obtain washed murine platelets free of contaminating plasma proteins and appropriate for studies of function, morphology, and thrombopoiesis |